In addition to melanoma, PLEKHA5 has also been associated with gastric cancer, with studies finding that tyrosine phosphorylation of PLEKHA5 is MET-dependent and associated with MET expression and phosphorylation. The gene discussed is MET; the disease is gastric cancer.